Next Phase of HCC Management and Research
Richard S. Finn, MD, Assistant Professor of Medicine, Division of Hematology/Oncology, Geffen School of Medicine, University of California explains the next phase of hepatocellular carcinoma (HCC) man... Author: obr Added: 06/27/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 27, 2019 Category: Cancer & Oncology Source Type: podcasts

KEYNOTE-240 in 1st Line HCC Outcome
Richard S. Finn, MD, Assistant Professor of Medicine, Division of Hematology/Oncology, Geffen School of Medicine, University of California explains the outcomes of hepatocellular carcinoma (HCC) in KE... Author: obr Added: 06/27/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 27, 2019 Category: Cancer & Oncology Source Type: podcasts

The Next Steps for an HCC Patient who Fails 1st Line Therapy
Imane El Dika, MD, Assistant Attending Physician, Memorial Sloan Kettering Cancer Center shares the next step for hepatocellular carcinoma (HCC) patient if the 1st line therapy fails. Author: obr Added: 06/26/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 26, 2019 Category: Cancer & Oncology Source Type: podcasts

Immuno-oncology in the Management of HCC
Imane El Dika, MD, Assistant Attending Physician, Memorial Sloan Kettering Cancer Center explains the role of immuno-oncology (I-O) in the management of hepatocellular carcinoma (HCC) with the recent... Author: obr Added: 06/26/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 26, 2019 Category: Cancer & Oncology Source Type: podcasts

Next Steps if Patient Fails 1st Line Therapy in HCC with Immunocology
Thomas A. Abrams Senior Physician and Assistant Professor of Medicine at Harvard Medical School explains the next steps a patient with hepatocellular carcinoma (HCC) can do if they fail the 1st line t... Author: obr Added: 06/25/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 25, 2019 Category: Cancer & Oncology Source Type: podcasts

Richard S. Finn, MD / Laura M. Kulik, MD - Rethinking Care in Hepatocellular Carcinoma Amid Expanding Treatment Options: An Interdisciplinary Discussion
Go online to PeerView.com/PDD860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, a multidisciplinary panel of interventional radiology, hepatology, and medical oncology experts provide an in-depth analysis of the latest data for approved and emerging systemic treatment options and recent evidence on locoregional and multimodal approaches for patients with HCC. In addition, the expert panel provides guidance on strategies to optimally select and timely transition between locoregional and systemic therapies. Upon completion of this activity, participants s...
Source: PeerView CME/CE Audio Podcast - Immunology - May 24, 2019 Category: Allergy & Immunology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts

Sequencing TKIs In Hepatocellular Carcinoma (HCC)
Nevena Damjanov, MD, Chief of GI Oncology, Abramson Cancer Center at Penn Presbyterian, University of Pennsylvania discusses, Sequencing TKIs In Hepatocellular Carcinoma (HCC). At The 2019 Gastrointes... Author: obr Added: 02/04/2019 (Source: Oncology Tube)
Source: Oncology Tube - February 4, 2019 Category: Cancer & Oncology Source Type: podcasts

The Utilization Of TKIs In Treatment Of Hepatocellular Carcinoma
Rachna Shroff, MD Chief, Section of GI Medical Oncology, Associate Professor of Medicine, Division of Hematology/Oncology, University of Arizona Cancer Center, discusses The Utilization Of TKIs In Tre... Author: obr Added: 01/29/2019 (Source: Oncology Tube)
Source: Oncology Tube - January 29, 2019 Category: Cancer & Oncology Source Type: podcasts

How We Can Utilize TKIs In The Management Of Hepatocellular Carcinoma
Richard Kim, MD, Gastrointestinal Oncology Department, Moffitt Cancer Center, Assistant Professor of Oncology, University of South Florida College of Medicine, discusses How We Can Utilize TKIs In The... Author: obr Added: 01/29/2019 (Source: Oncology Tube)
Source: Oncology Tube - January 29, 2019 Category: Cancer & Oncology Source Type: podcasts

Jorge A. Marrero, MD, MS - Surveying the View From the Driver ’s Seat in Hepatocellular Carcinoma: Bringing Into Focus Hepatology’s Key Role in Guiding HCC Care Down the Path to Improved Outcomes
Surveying the View From the Driver’s Seat in Hepatocellular Carcinoma: Bringing Into Focus Hepatology’s Key Role in Guiding HCC Care Down the Path to Improved Outcomes (Source: PeerView CME/CE Audio Podcast - Oncology)
Source: PeerView CME/CE Audio Podcast - Oncology - January 12, 2019 Category: Cancer & Oncology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts

Jorge A. Marrero, MD, MS - Surveying the View From the Driver ’s Seat in Hepatocellular Carcinoma: Bringing Into Focus Hepatology’s Key Role in Guiding HCC Care Down the Path to Improved Outcomes
Surveying the View From the Driver’s Seat in Hepatocellular Carcinoma: Bringing Into Focus Hepatology’s Key Role in Guiding HCC Care Down the Path to Improved Outcomes (Source: PeerView CME/CE Audio Podcast - Immunology)
Source: PeerView CME/CE Audio Podcast - Immunology - January 11, 2019 Category: Allergy & Immunology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts

JAMA Oncology : Analgesic Use and Risk of Ovarian Cancer in the Nurses ’ Health Studies
Interview with Mollie E. Barnard, ScD, and Shelley Tworoger, PhD, authors of Association of Analgesic Use With Risk of Ovarian Cancer in the Nurses’ Health Studies, and Andrew T. Chan, MD, MPH, author of Association Between Aspirin Use and Risk of Hepatocellular Carcinoma (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - October 4, 2018 Category: General Medicine Source Type: podcasts

Hepatocellular Carcinoma: A Guide to Integrating Emerging Therapies into Current Treatment Paradigms
Recent approvals in hepatocellular carcinoma (HCC) have increased the treatment options available for patients with this disease, leading to improved clinical outcomes. However, there is no single tre... Author: imedex Added: 09/14/2018 (Source: Oncology Tube)
Source: Oncology Tube - September 14, 2018 Category: Cancer & Oncology Source Type: podcasts

The shortcomings of the RECIST study in HCC
Ghassan Abou-Alfa, MD, MBA, explains the shortcomings of the RECIST study in measuring efficacy in hepatocellular carcinoma (HCC) patients at ASCO 2018. Author: obr Added: 07/20/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 20, 2018 Category: Cancer & Oncology Source Type: podcasts

The latest in systemic therapy for advanced HCC
Ghassan Abou-Alfa, MD, MBA, talks about the latest in systemic therapy for advanced hepatocellular carcinoma (HCC) at the 2018 ASCO Annual Meeting Author: obr Added: 07/19/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 19, 2018 Category: Cancer & Oncology Source Type: podcasts

Sensitivity for BCLC for Stage A was 93% & #124; Detect Hepatocellular Carcinoma Lesions in Future
Dr. John Kisiel, MD, Mayo Clinic, talks Sensitivity for BCLC for Stage A was 93%| Detect Hepatocellular Carcinoma Lesions in Future for DDW 2018. Author: Cancer-News Added: 07/16/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 16, 2018 Category: Cancer & Oncology Source Type: podcasts

Develop Novel, Non-Invasive Biomarkers | Clinical Validation Study in Hepatocellular Carcinoma
Dr. John Kisiel, MD, Mayo Clinic, talks about Develop Novel, Non-Invasive Biomarkers | Clinical Validation Study in Hepatocellular Carcinoma for DDW 2018. Author: Cancer-News Added: 07/16/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 16, 2018 Category: Cancer & Oncology Source Type: podcasts

Riccardo Lencioni, MD, FSIR, EBIR - At the Intersection of Local and Systemic Therapy in the Management of Hepatocellular Carcinoma: Preparing for the Next Evolution in Multimodal Treatment
At the Intersection of Local and Systemic Therapy in the Management of Hepatocellular Carcinoma: Preparing for the Next Evolution in Multimodal Treatment (Source: PeerView CME/CE Audio Podcast - Immunology)
Source: PeerView CME/CE Audio Podcast - Immunology - May 28, 2018 Category: Allergy & Immunology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts

Ghassan Abou-Alfa, MD, MBA - Teaming Up to Improve Outcomes in Advanced Hepatocellular Carcinoma: A Tumor Board Evaluating the Potential of Immunotherapy and Novel Targeted Approaches
Teaming Up to Improve Outcomes in Advanced Hepatocellular Carcinoma: A Tumor Board Evaluating the Potential of Immunotherapy and Novel Targeted Approaches (Source: PeerView CME/CE Audio Podcast - Gastroenterology)
Source: PeerView CME/CE Audio Podcast - Gastroenterology - May 3, 2018 Category: Gastroenterology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts

Ghassan Abou-Alfa, MD, MBA - New Options, Emerging Combinations in Advanced Hepatocellular Carcinoma: Are Management Approaches Poised For Transformation?
New Options, Emerging Combinations in Advanced Hepatocellular Carcinoma: Are Management Approaches Poised For Transformation? (Source: PeerView CME/CE Audio Podcast - Immunology)
Source: PeerView CME/CE Audio Podcast - Immunology - April 14, 2018 Category: Allergy & Immunology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts

New Guidelines for HCC: The Big Questions Tackled
Dr David Johnson provides clinicians with an overview of the new guidelines from the American Association for the Study of Liver Diseases (AASLD) on hepatocellular carcinoma. (Source: Medscape Gastroenterology Podcast)
Source: Medscape Gastroenterology Podcast - February 21, 2018 Category: Gastroenterology Authors: Medscape Source Type: podcasts

Whiteboard Video: The Epidemiology of Hepatocellular Carcinoma and Current Standard of Care
Tyrosine kinase inhibitors (TKIs) are orally active, small molecules that exhibit antitumor activity by targeting enzymes that play a critical role cellular functions, including modulation of growth f... Author: imedex Added: 02/06/2018 (Source: Oncology Tube)
Source: Oncology Tube - February 6, 2018 Category: Cancer & Oncology Source Type: podcasts

Velocity Vlog: Role of TKIs in Hepatocellular Carcinoma - Recent Updates
In this Velocity Vlog activity, Dr. Richard S. Finn of the UCLA Geffen School of Medicine, provides a brief overview of the epidemiology of hepatocellular carcinoma and then discusses current standar... Author: imedex Added: 02/06/2018 (Source: Oncology Tube)
Source: Oncology Tube - February 6, 2018 Category: Cancer & Oncology Source Type: podcasts

The Use And Sequencing Of Tyrosine Kinase Inhibitors(TKIs) In Hepatocellular Carcinoma (HCC)
Only one TKI is approved in a first line setting. Joining us from the 2018 Gastrointestinal Cancers Symposium is Dr. Richard Kim, MD, Gastrointestinal Oncology Department, Moffitt Cancer Center, Assis... Author: obr Added: 01/30/2018 (Source: Oncology Tube)
Source: Oncology Tube - January 30, 2018 Category: Cancer & Oncology Source Type: podcasts

Hepatocelluar Carcinoma (HCC) Treatment Response Through Imaging Assessment
Determining the progression and the responses of Hepatocellular Carcinoma (HCC). Professor Andrew X. Zhu, MD, PhD from Harvard Medical School and also the Director of Liver Cancer Research, comes to u... Author: obr Added: 01/29/2018 (Source: Oncology Tube)
Source: Oncology Tube - January 29, 2018 Category: Cancer & Oncology Source Type: podcasts

HCC under the microscope: From bench to bedside
In this presentation from the 'Looking Closely at New Therapeutic Options for Hepatocellular Carcinoma', Dr. Bruno Daniele discusses the latest advances in translational medicine for hepatocellular ca... Author: imedex Added: 01/11/2018 (Source: Oncology Tube)
Source: Oncology Tube - January 11, 2018 Category: Cancer & Oncology Source Type: podcasts

New treatment approaches for advanced, unresectable HCC
In this presentation from the 'Looking Closely at New Therapeutic Options for Hepatocellular Carcinoma', Dr. Jordi Bruix discusses novel treatment approaches for patients with advanced, unresectable h... Author: imedex Added: 01/11/2018 (Source: Oncology Tube)
Source: Oncology Tube - January 11, 2018 Category: Cancer & Oncology Source Type: podcasts

New developments in locoregional treatments for HCC
In this presentation from the 'Looking Closely at New Therapeutic Options for Hepatocellular Carcinoma', Dr. Luigi Bolondi discusses the latest advancements in locoregional therapy for patients with h... Author: imedex Added: 01/11/2018 (Source: Oncology Tube)
Source: Oncology Tube - January 11, 2018 Category: Cancer & Oncology Source Type: podcasts

Ghassan Abou-Alfa, MD, MBA - The Expanding Role of the Hepatologist in Interdisciplinary Hepatocellular Carcinoma Management: Achieving the Full Potential of Targeted Therapy and Immunotherapy Advances
The Expanding Role of the Hepatologist in Interdisciplinary Hepatocellular Carcinoma Management: Achieving the Full Potential of Targeted Therapy and Immunotherapy Advances (Source: PeerView Press CME/CE International Audio Podcast - Internal Medicine)
Source: PeerView Press CME/CE International Audio Podcast - Internal Medicine - December 9, 2017 Category: Internal Medicine Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts

Debate: Is there a standard second line therapy for HCC? - Regorafenib is a winner
In this presentation from the 2017 Great Debates & Updates in GI Malignancies, Dr. Ghassan Abou-Alfa argues that regorafenib should be the standard second line therapy for hepatocellular carcinoma (HC... Author: imedex Added: 08/23/2017 (Source: Oncology Tube)
Source: Oncology Tube - August 23, 2017 Category: Cancer & Oncology Source Type: podcasts

Update: Novel treatments for HCC in the era of hepatitis C therapies
In this presentation from the 2017 Great Debates & Updates in GI Malignancies, Dr. Ghassan Abou-Alfa provides an update in novel treatments for hepatocellular carcinoma (HCC) in the era of hepatitis C... Author: imedex Added: 08/14/2017 (Source: Oncology Tube)
Source: Oncology Tube - August 14, 2017 Category: Cancer & Oncology Source Type: podcasts

Anthony El-Khoueiry, MD - Looking to the Future in Hepatocellular Carcinoma: A Master Class on Current and Emerging Therapeutic Strategies
Looking to the Future in Hepatocellular Carcinoma: A Master Class on Current and Emerging Therapeutic Strategies (Source: PeerView CME/CE Audio Podcast - Primary Care)
Source: PeerView CME/CE Audio Podcast - Primary Care - July 21, 2017 Category: Primary Care Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts

Lenvatinib in unresectable HCC
Philip Philip, MD of Karmanos Cancer Institute discusses the use of lenvatinib in patients with unresectable hepatocellular carcinoma (HCC) at the 2017 ASCO Annual Meeting in Chicago, IL. Author: obr Added: 06/22/2017 (Source: Oncology Tube)
Source: Oncology Tube - June 22, 2017 Category: Cancer & Oncology Source Type: podcasts

Is SIRT effective in the treatment of metastatic HCC?
Jeffrey Meyehardt, MD of Harvard Medical School explains whether or not selective internal radiation therapy (SIRT) is effective in treating metastatic hepatocellular carcinoma (HCC) at the 2017 ASCO ... Author: obr Added: 06/21/2017 (Source: Oncology Tube)
Source: Oncology Tube - June 22, 2017 Category: Cancer & Oncology Source Type: podcasts

Lenvatinib in the 1st line for uHCC treatment
Nevena Damnjanov, MD of Abramson Cancer Center at Penn Presbyterian, University of Pennsylvania discusses the use of lenvatinib in the first line setting for the treatment of hepatocellular carcinoma.... Author: obr Added: 06/20/2017 (Source: Oncology Tube)
Source: Oncology Tube - June 20, 2017 Category: Cancer & Oncology Source Type: podcasts

Impact of Regorafenib for HCC
Ghassan Abou-Alfa, MD of Memorial Sloan-Kettering discusses the impact of regorafenib for hepatocellular carcinoma (HCC) treatment. This was recorded at the 2017 Great Debates and Updates in GI Malign... Author: GiDebates2017 Added: 05/31/2017 (Source: Oncology Tube)
Source: Oncology Tube - May 31, 2017 Category: Cancer & Oncology Source Type: podcasts

Is There a Standard Second Line Therapy for HCC?
Tanios S. Bekaii-Saab, MD, FACP of Mayo Clinic explains whether or not there is a standard second line treatment for patients with hepatocellular carcinoma (HCC) and who failed first line therapy. He ... Author: GiDebates2017 Added: 05/26/2017 (Source: Oncology Tube)
Source: Oncology Tube - May 26, 2017 Category: Cancer & Oncology Source Type: podcasts

New targets and new agents in HCC
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Eric Raymond discusses new targets and agents for the treatment of hepatocellular carcinoma (HCC). Author: imedex Added: 09/01/2016 (Source: Oncology Tube)
Source: Oncology Tube - September 2, 2016 Category: Cancer & Oncology Source Type: podcasts

Tandem Talk 3: Hepatocellular carcinoma - Locoregional Treatment
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Chris Verslype arguest for the locoregional treatment of hepatocellular carcinoma (HCC). Author: imedex Added: 09/01/2016 (Source: Oncology Tube)
Source: Oncology Tube - September 2, 2016 Category: Cancer & Oncology Source Type: podcasts

Immunotherapy for hepatocellular carcinoma
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Su Pin Choo, MBBS, MRCP(UK), FAMS, from the National Cancer Centre Singa... Author: EMJ Added: 02/24/2016 (Source: Oncology Tube)
Source: Oncology Tube - February 24, 2016 Category: Cancer & Oncology Source Type: podcasts

Debate 11: Locally-advanced Hepatocellular Carcinoma (HCC) - Surgery is optimal
Filmed on location in New York during the Great Debates and Updates in GI Malignancies 2015, this webcast is part of a series that provides educational discussions on controversial areas in the manage... Author: imedex Added: 08/11/2015 (Source: Oncology Tube)
Source: Oncology Tube - August 11, 2015 Category: Cancer & Oncology Source Type: podcasts

Debate 11: Locally-advanced Hepatocellular Carcinoma (HCC) - IR-directed Therapy
Filmed on location in New York during the Great Debates and Updates in GI Malignancies 2015, this webcast is part of a series that provides educational discussions on controversial areas in the manage... Author: imedex Added: 08/11/2015 (Source: Oncology Tube)
Source: Oncology Tube - August 11, 2015 Category: Cancer & Oncology Source Type: podcasts

Update 14: Recent advances in management of advanced Hepatocellular Carcinoma (HCC)
Filmed on location in New York during the Great Debates and Updates in GI Malignancies 2015, this webcast is part of a series that provides educational discussions on controversial areas in the manage... Author: imedex Added: 08/11/2015 (Source: Oncology Tube)
Source: Oncology Tube - August 11, 2015 Category: Cancer & Oncology Source Type: podcasts

Erythropoietin for TBI, HSCT for severe sickle cell diseaes, everolimus for hepatocellular carcinoma, and more.
Editor's Audio Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the July 02, 2014 issue (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - July 1, 2014 Category: Journals (General) Authors: JAMA, the Journal of the American Medical Association, and The JAMA Network Source Type: podcasts

July 2014: Repeatability of Diagnostic Features and Scoring Systems
ARTICLES DISCUSSED: Repeatability of Diagnostic Features and Scoring Systems for Hepatocellular Carcinoma by Using MR Imaging. Radiology 2014;272(1):132-142. The Radiologist as Interpreter and Translator. Radiology 2014;272(1):4-8. (Source: Radiology Podcasts)
Source: Radiology Podcasts - June 19, 2014 Category: Radiology Authors: webmaster at rsna.org Tags: Podcasts Source Type: podcasts

Liver Cancer: Hepatocellular Carcinoma
A specialist in both gastroenterology and hepatology, Dr. David Koch discusses primary liver cancer, noting reasons for increased risk of this disease. He goes over the process from screening through diagnosis and treatment. In this cancer podcast, Dr. Koch focuses on the benefits of liver resection or transplantation for patient prognosis. He concludes by noting research efforts coming about at MUSC. (Source: MUSC Organ Transplantation Surgery Podcast)
Source: MUSC Organ Transplantation Surgery Podcast - April 6, 2014 Category: Transplant Surgery Authors: Medical Univeristy of South Carolina Source Type: podcasts

Liver Cancer: Hepatocellular Carcinoma
A specialist in both gastroenterology and hepatology, Dr. David Koch discusses primary liver cancer, noting reasons for increased risk of this disease. He goes over the process from screening through diagnosis and treatment. In this cancer podcast, Dr. Koch focuses on the benefits of liver resection or transplantation for patient prognosis. He concludes by noting research efforts coming about at MUSC. (Source: MUSC Digestive Health Podcast)
Source: MUSC Digestive Health Podcast - April 5, 2014 Category: Gastroenterology Authors: Medical University of South Carolina Source Type: podcasts

Andrew X. Zhu, MD, PhD - Expert Perspectives on the Promises and Limitations of Expanded Use of Systemic Therapies Throughout the Hepatocellular Carcinoma Disease Continuum
(Source: PeerView Press CME/CE International Audio Podcast - Internal Medicine)
Source: PeerView Press CME/CE International Audio Podcast - Internal Medicine - November 14, 2013 Category: Internal Medicine Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts

August 2013: Unresectable hepatocellular carcinoma
ARTICLES DISCUSSED: Unresectable hepatocellular carcinoma: MR imaging after intraarterial therapy. Part I: Identification and validation of volumetric functional response criteria. Radiology 2013;268(2):420-430. Part II: Response stratification using volumetric functional criteria after intraarterial therapy. Radiology 2013;268(2):431-439. (Source: Radiology Podcasts)
Source: Radiology Podcasts - July 22, 2013 Category: Radiology Authors: webmaster at rsna.org Tags: Podcasts Source Type: podcasts